NextPoint Therapeutics, Inc., 2026-07-30
A new SEC Form D private-offering notice from Cambridge, MA, a $48,729,165 filer-stated offering target in Biotech. The source filing is one click away.
What this filing says
Clinical stage biotech developing precision immuno-oncology therapies targeting the B7-H7 (HHLA2) checkpoint pathway for patients who do not respond to PD-1/L1 inhibitors.
This is a public SEC Form D private-offering notice, the filer's own statement to the SEC. Amounts are offering targets, not confirmed closes. Takeoff Radar pulls Form D nightly from EDGAR and links every filing to its source.
Other Form D filings from the same week
each with its own page and its own EDGAR source- Quantum Network Technologies, Inc., 2026-08-03, $3M, Boston, MA
- Ratio Therapeutics, Inc., 2026-07-31, $70M, Boston, MA
- KaiAvora Health, LLC, 2026-07-31, $750K, Medford, MA
- Enumera Molecular, Inc., 2026-07-31, $17.4M, Ann Arbor, MI
- Biota Inc., 2026-07-30, $3.2M, Longmont, CO
- WaveGuide Corp, 2026-07-30, $2.8M, Waltham, MA
The Monday digest, free
A summary of who raised money last week: the ones worth a call first, then every company that filed, by state and sector. One email, Monday mornings. No spam, unsubscribe anytime.
By subscribing you agree to our Terms and Privacy Policy.